Decentralized clinical trial models are designed to take a hospital visit to the patient. By allowing trial visits to be conducted outside of the site, DCT allows physicians to expand their reach making drug development more accessible to people.
By bringing the trial to the patient's own community DCTs are making participation easier for patients, reducing the need for travel and resulting in a positive impact on recruitment and retention rates.
Successfully delivering decentralized clinical trial visits is a complex process. Read about how MRN's Home Trial Support 'HTS' is the engine that powers DCT.